Last CNY7.66 CNY
Change Today +0.04 / 0.52%
Volume 2.3M
600664 On Other Exchanges
Symbol
Exchange
Shanghai
As of 9:19 PM 11/20/14 All times are local (Market data is delayed by at least 15 minutes).

harbin pharmaceutical grp-a (600664) Snapshot

Open
CNY7.64
Previous Close
CNY7.62
Day High
CNY7.67
Day Low
CNY7.61
52 Week High
09/10/14 - CNY8.95
52 Week Low
02/7/14 - CNY5.57
Market Cap
14.7B
Average Volume 10 Days
37.8M
EPS TTM
CNY0.12
Shares Outstanding
1.9B
EX-Date
08/26/14
P/E TM
63.3x
Dividend
CNY0.07
Dividend Yield
0.86%
Current Stock Chart for HARBIN PHARMACEUTICAL GRP-A (600664)

Related News

No related news articles were found.

harbin pharmaceutical grp-a (600664) Related Businessweek News

No Related Businessweek News Found

harbin pharmaceutical grp-a (600664) Details

Harbin Pharmaceutical Group Co., Ltd. is engaged in the research and development, manufacture, and trading of pharmaceutical products. It offers antibiotics, small-molecular drug preparations, OTC and healthcare products, Chinese medicines, biopharmaceuticals, animal vaccines, and medicine circulations. The company’s APIs include penicillin and cephalosporin products, and other pharmaceutical intermediates in various dosage forms, such as injections, injectable powders, oral solutions, tablets, and capsules. The company markets its products primarily to Europe, Asia, Africa, and Middle and North America. Harbin Pharmaceutical Group Co., Ltd. is based in Harbin, China.

harbin pharmaceutical grp-a (600664) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

harbin pharmaceutical grp-a (600664) Key Developments

Harbin Pharmaceutical Group Co., Ltd., Board Meeting, Oct 20, 2014

Harbin Pharmaceutical Group Co., Ltd., Board Meeting, Oct 20, 2014. Agenda: To discuss and approve the proposal of changing its accounting policy.

Harbin Pharmaceutical Announces Earnings Results for the Nine Months Ended September 2014

Harbin Pharmaceutical announced earnings results for the nine months ended September 2014. The company posted a 23.4% rise in net profit to CNY 325.6 million for the period. This compares with CNY 263.8 million for the same period in 2013. Revenue for the period was CNY 13 billion, against CNY 13.72 billion in 2013, marking a fall of 5%.

Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Three Quarters of 2014

Harbin Pharmaceutical Group Co., Ltd. reported earnings results for the first three quarters of 2014. For the period, the company reported basic earning per share was CNY 0.1698. Weighted average return on net assets was CNY 3.95.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600664:CH CNY7.66 CNY +0.04

600664 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China BCT Pharmacy Group Inc $0.02 USD 0.00
Kirin Holdings Co Ltd ¥1,479 JPY -7.50
Roche Holding AG SFr.288.30 CHF 0.00
View Industry Companies
 

Industry Analysis

600664

Industry Average

Valuation 600664 Industry Range
Price/Earnings 62.2x
Price/Sales 0.9x
Price/Book 1.8x
Price/Cash Flow 63.7x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HARBIN PHARMACEUTICAL GRP-A, please visit www.hayao.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.